TD
Translational Development Acquisition Corp.
TDACW · NASDAQ
$1.48 +355.38% (+$1.16)
1M -3.77%
Market Cap $35.7M
P/E Ratio 6.45x
Div. Yield -
ROE 3.28%
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/E 6.45x
P/B 0.24x
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
Book val. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
FCF margin N/A
Quality
36 /100
Average ROE 3.28%
ROA 3.52%
Asset turnover 0.00x
Debt
0 /100
High Current ratio 0.06x
Debt/Equity N/A
Int. coverage N/A
Stability
0 /100
Unstable Beta 2.11x
Rev. volatility N/A
EPS volatility N/A
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about TDACW
Online
Sector
Financial Services
Industry
Shell Companies
CEO
Michael Hoffman
Employees
2
Headquarters
New York City